| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/ACS.JMEDCHEM.6B01178 |
| P8608 | Fatcat ID | release_rijlhd2x5ndjbc75skliejtgnq |
| P698 | PubMed publication ID | 27736061 |
| P50 | author | Alejandro Romero Martínez | Q39676340 |
| Rafael León | Q41539388 | ||
| Javier Egea | Q41539393 | ||
| Maria Luisa Jimeno | Q42861473 | ||
| Olivier Ouari | Q43067115 | ||
| Daniel Jun | Q43132216 | ||
| Jana Janockova | Q50171422 | ||
| Vendula Sepsova | Q56704796 | ||
| Mohamed Benchekroun | Q56956713 | ||
| Oscar Bautista | Q64861764 | ||
| Izaskun Buendia | Q85891009 | ||
| Patrycja Michalska | Q86547085 | ||
| P2093 | author name string | José Marco-Contelles | |
| Lhassane Ismaili | |||
| Ondrej Soukup | |||
| Bernard Refouvelet | |||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| melatonin | Q180912 | ||
| P304 | page(s) | 9967-9973 | |
| P577 | publication date | 2016-10-13 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators | |
| P478 | volume | 59 |
| Q90609511 | Current and emerging therapeutic targets of alzheimer's disease for the design of multi-target directed ligands |
| Q90399710 | Design, Synthesis and Biological Evaluation of New Antioxidant and Neuroprotective Multitarget Directed Ligands Able to Block Calcium Channels |
| Q58557671 | Design, Synthesis of -phenethyl Cinnamide Derivatives and Their Biological Activities for the Treatment of Alzheimer's Disease: Antioxidant, Beta-amyloid Disaggregating and Rescue Effects on Memory Loss |
| Q36329594 | Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's disease |
| Q61800275 | Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy |
| Q90698665 | Evidence supporting oxidative stress in a moderately affected area of the brain in Alzheimer's disease |
| Q89768077 | Lipophilic Antioxidants and Cognitive Function in the Elderly |
| Q38684594 | Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration |
| Q92084454 | Multicomponent Synthesis of Polyphenols and their in vitro Evaluation as Potential β-Amyloid Aggregation Inhibitors |
| Q47583431 | Multicomponent, fragment-based synthesis of polyphenol-containing peptidomimetics and their inhibiting activity on beta-amyloid oligomerization |
| Q64250319 | Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments |
| Q61804015 | Role of immune-pineal axis in neurodegenerative diseases, unraveling novel hybrid dark hormone therapies |
| Q59807620 | Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer's disease therapy |
| Q92702372 | Synthesis of novel vanillin derivatives: novel multi-targeted scaffold ligands against Alzheimer's disease |
Search more.